Gene Editing Study reveals serum proteomic signatures of long COVID patients Posted on May 12, 2022 by Editorial Staff In a recent study posted to the bioRxiv*preprint server, researchers evaluated the serum proteomic signatures of long coronavirus disease (COVID) patients. Share on FacebookTweetFollow us Editorial Staff SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions STAT+: 3 burning questions about the future of prescribing drugs online